Combined treatment of disulfiram with PARP inhibitors suppresses ovarian cancer

INTRODUCTION: Due to the difficulty of early diagnosis, nearly 70% of ovarian cancer patients are first diagnosed at an advanced stage. Thus, improving current treatment strategies is of great significance for ovarian cancer patients. Fast-developing poly (ADP-ribose) polymerases inhibitors (PARPis)...

Descripción completa

Detalles Bibliográficos
Autores principales: Tang, Bin, Wu, Min, Zhang, Lin, Jian, Shuyi, Lv, Shiyi, Lin, Tongyuan, Zhu, Shuangshuang, Liu, Layang, Wang, Yixue, Yi, Zhengfang, Jiang, Feiyun
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2023
Materias:
Oncology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10151711/
https://www.ncbi.nlm.nih.gov/pubmed/37143950
http://dx.doi.org/10.3389/fonc.2023.1154073

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10151711/
https://www.ncbi.nlm.nih.gov/pubmed/37143950
http://dx.doi.org/10.3389/fonc.2023.1154073

Ejemplares similares